MSMS Board discusses Prescription Drug Diversion, MAPS, new continuing medical education rules at meeting

News & Media

MSMS Board discusses Prescription Drug Diversion, MAPS, new continuing medical education rules at meeting

Friday, January 27, 2017

Earlier this week, the Michigan State Medical Society (MSMS) Board of Directors heard from Kim Gaedeke, Director, Bureau of Professional Licensing for the State of Michigan, regarding the current status of the upgrades to the Michigan Automated Prescription System (MAPS) and Leland A. Babitch, MD, MBA, President and CEO of MPRO, who shared their work in the areas of quality improvement, review services, and consulting. Additionally, the board discussed legislative priorities for the upcoming year, and the new continuing medical education rules.

Prescription Drug Diversion: With Prescription Drug Diversion as one of the early priorities of the legislatures, Kim Gaedeke gave a presentation on the process of the upgrades to the Michigan Automated Prescription System (MAPS). As directed by our House of Delegates, upgrading the software platform is a crucial element in improving and measuring physician use of MAPS and thereby serving to help reduce the amount of prescription drugs available for illicit purposes.

MPRO: Recently appointed as the president and chief executive officer of MPRO, Leland A. Babitch, MD, MBA, provided an overview of their work. Their quality improvement activities are primarily funded by a grant from the Centers for Medicare and Medicaid Services (CMS). This grant is to improve patient care by sharing best practices with physicians as it relates to heart health, diabetes, care coordination, adverse drug events, antibiotic stewardship, MIPS/ABMs, adult immunizations and behavioral health. MSMS will be partnering with MPRO on MACRA education for physicians.

Legislative Priorities: With the 2015-2016 legislative session ending in December, the Legislative Policy Committee built a strategy and identified priorities for the committee. Those priorities include:

  • A regular invitation to legislators, interest groups, or other key stakeholders in order to better deliver the message of physicians and gain valuable perspective to help shape policy within MSMS.
  • Building opportunities for members of the MSMS Board of Directors to interact with their elected officials on behalf of MSMS.
  • Legislative Policy Committee can help to better shape the dynamics of the relationship between the MSMS Board and the Committee on State Legislation and Regulations and how the unique strengths of each group can serve one another and thus better serve physicians.
  • The Committee discussed taking an active role in specific areas of interest, including: the inexplicable rise of prescription drug costs to consumers, Medicaid Expansion, and issues that contribute to damaging the physician-patient relationship such as confusion over coverage, insurer responsibility for collection of co-pays, and the expectations of insurers with respect to high deductible plans.

New Continuing Medical Education Rules: In December 2016, the Michigan Department of Licensing and Regulatory Affairs announced revised Medical Rules. Significant changes to be aware of include:

  • Training standards for identifying victims of human trafficking. This is a one-time training that is separate from continuing education. Licensees renewing for 2017 must complete training by renewal in 2020; renewals for 2018 by 2021, and renewals for 2019 by 2022. Beginning in 2021, completion of the training is a requirement for initial licensure.
  • Starting in December 2017, a minimum of three hours of continuing education shall be earned in the area of pain and symptom management.

Please visit for online programming for both of these requirements.